Works by Nakagawa, Kazuhiko


Results: 278
    1

    Docetaxel Plus RAmucirumab With Primary Prophylactic Pegylated Granulocyte-ColONy Stimulating Factor Support for Elderly Patients With Advanced Non-small-cell Lung Cancer: A Multicenter Prospective Single Arm Phase II Trial: DRAGON Study (WJOG9416L).

    Published in:
    2018
    By:
    • Akito Hata;
    • Nobuyuki Katakami;
    • Mototsugu Shimokawa;
    • Tetsuya Mitsudomi;
    • Nobuyuki Yamamoto;
    • Kazuhiko Nakagawa;
    • Hata, Akito;
    • Katakami, Nobuyuki;
    • Shimokawa, Mototsugu;
    • Mitsudomi, Tetsuya;
    • Yamamoto, Nobuyuki;
    • Nakagawa, Kazuhiko
    Publication type:
    journal article
    2
    3
    4

    Treatment Rationale and Study Design for the RELAY Study: A Multicenter, Randomized, Double-Blind Study of Erlotinib With Ramucirumab or Placebo in Patients With Epidermal Growth Factor Receptor Mutation- Positive Metastatic Non—Small-Cell Lung Cancer.

    Published in:
    2017
    By:
    • Garon, Edward B.;
    • Reck, Martin;
    • Paz-Ares, Luis;
    • Ponce, Santiago;
    • Jaime, Jesus Corral;
    • Juan, Oscar;
    • Nadal, Ernest;
    • Lee, Pablo;
    • Dalai, Rita;
    • Jingyi Liu;
    • Shuang He;
    • Treat, Joseph;
    • Kazuhiko Nakagawa;
    • Dalal, Rita;
    • Liu, Jingyi;
    • He, Shuang;
    • Nakagawa, Kazuhiko
    Publication type:
    journal article
    5

    Progression-Free and Overall Survival of Patients With ALK Rearrangement-Positive Non-Small Cell Lung Cancer Treated Sequentially With Crizotinib and Alectinib.

    Published in:
    2016
    By:
    • Satomi Watanabe;
    • Hidetoshi Hayashi;
    • Kunio Okamoto;
    • Kimiko Fujiwara;
    • Yoshikazu Hasegawa;
    • Hiroyasu Kaneda;
    • Kaoru Tanaka;
    • Masayuki Takeda;
    • Kazuhiko Nakagawa;
    • Watanabe, Satomi;
    • Hayashi, Hidetoshi;
    • Okamoto, Kunio;
    • Fujiwara, Kimiko;
    • Hasegawa, Yoshikazu;
    • Kaneda, Hiroyasu;
    • Tanaka, Kaoru;
    • Takeda, Masayuki;
    • Nakagawa, Kazuhiko
    Publication type:
    journal article
    6
    7
    8
    9

    Veliparib Plus Carboplatin and Paclitaxel Versus Investigator's Choice of Standard Chemotherapy in Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer.

    Published in:
    Clinical Lung Cancer, 2022, v. 23, n. 3, p. 214, doi. 10.1016/j.cllc.2022.01.005
    By:
    • Govindan, Ramaswamy;
    • Lind, Mike;
    • Insa, Amelia;
    • Khan, Saad A.;
    • Uskov, Dmitry;
    • Tafreshi, Ali;
    • Guclu, Salih;
    • Bar, Jair;
    • Terufumi Kato;
    • Ki Hyeong Lee;
    • Kazuhiko Nakagawa;
    • Hansen, Olfred;
    • Biesma, Bonne;
    • Kundu, Madan G.;
    • Dunbar, Martin;
    • Lei He;
    • Ansell, Peter;
    • Sehgal, Vasudha;
    • Xin Huang;
    • Glasgow, Jaimee
    Publication type:
    Article
    10
    11
    12

    Phase I study of TZT-1027, a novel synthetic dolastatin 10 derivative and inhibitor of tubulin polymerization, which was administered to patients with advanced solid tumors on days 1 and 8 in 3-week courses.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2007, v. 60, n. 2, p. 285, doi. 10.1007/s00280-006-0382-7
    By:
    • Tamura, Kenji;
    • Nakagawa, Kazuhiko;
    • Kurata, Takayasu;
    • Satoh, Taroh;
    • Nogami, Toshiji;
    • Takeda, Koji;
    • Mitsuoka, Shigeki;
    • Yoshimura, Naruo;
    • Kudoh, Shinzoh;
    • Negoro, Shunichi;
    • Fukuoka, Masahiro
    Publication type:
    Article
    13
    14
    15
    16
    17
    18
    19

    Review of 200 Stapled Functional End-to-End Anastomoses.

    Published in:
    Digestive Surgery, 1993, v. 10, n. 5, p. 245, doi. 10.1159/000172185
    By:
    • Kusunoki, Masato;
    • Yanagi, Hidenori;
    • Sakanoue, Youichirou;
    • Shoji, Yasutsugu;
    • Nakagawa, Kazuhiko;
    • Yamamura, Takehira;
    • Utsunomiya, Joji
    Publication type:
    Article
    20

    Progression from early to advanced stage of immune‐related cholangitis.

    Published in:
    Hepatology Research, 2022, v. 52, n. 10, p. 888, doi. 10.1111/hepr.13817
    By:
    • Hagiwara, Satoru;
    • Yoshida, Takeshi;
    • Nishida, Naoshi;
    • Ida, Hiroshi;
    • Ueshima, Kazuomi;
    • Minami, Yasunori;
    • Takita, Masahiro;
    • Aoki, Tomoko;
    • Morita, Masahiro;
    • Cishina, Hirokazu;
    • Komeda, Yoriaki;
    • Yoshida, Akihiro;
    • Hayashi, Hidetoshi;
    • Nakagawa, Kazuhiko;
    • Kudo, Masatoshi
    Publication type:
    Article
    21
    22

    Amyloid Colitis: Successful Treatment with Colchicine Therapy.

    Published in:
    Digestive Endoscopy, 1998, v. 10, n. 3, p. 216, doi. 10.1111/j.1443-1661.1998.tb00561.x
    By:
    • HIRASAKI, Shoji;
    • KOIDE, Norio;
    • NAKAGAWA, Kazuhiko;
    • SHIMA, Yasuo;
    • OGAWA, Hiromichi;
    • UJIKE, Kozo;
    • OKADA, Hiroyuki;
    • MIZUNO, Motowo;
    • UKIDA, Minora;
    • TSUJI, Takao
    Publication type:
    Article
    23

    Significance of micro-EGFR T790M mutations on EGFR-tyrosine kinase inhibitor efficacy in non-small cell lung cancer.

    Published in:
    Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-45337-3
    By:
    • Masuda, Takeshi;
    • Miura, Satoru;
    • Sato, Yuki;
    • Tachihara, Motoko;
    • Bessho, Akihiro;
    • Nakamura, Atsushi;
    • Miyawaki, Taichi;
    • Yoshimine, Kohei;
    • Mori, Masahide;
    • Shiraishi, Hideaki;
    • Hamai, Kosuke;
    • Haratani, Koji;
    • Maeda, Sumiko;
    • Tabata, Eriko;
    • Kitagawa, Chiyoe;
    • Tanizaki, Junko;
    • Imai, Takumi;
    • Nogami, Shohei;
    • Yamamoto, Nobuyuki;
    • Nakagawa, Kazuhiko
    Publication type:
    Article
    24
    25
    26
    27

    Prognostic impact of geriatric assessment in elderly patients with non-small cell lung cancer: an integrated analysis of two randomized phase III trials (JCOG1115-A).

    Published in:
    Japanese Journal of Clinical Oncology, 2021, v. 51, n. 5, p. 685, doi. 10.1093/jjco/hyaa257
    By:
    • Katayama, Hiroshi;
    • Mizusawa, Junki;
    • Fukuda, Haruhiko;
    • Nakamura, Shinichiro;
    • Nakamura, Kenich;
    • Saijo, Nagahiro;
    • Yokoyama, Akira;
    • Ohe, Yuichro;
    • Shinkai, Tetsu;
    • Nakagawa, Kazuhiko;
    • Abe, Tetsuya;
    • Mitsuoka, Shigeki;
    • Okamoto, Hiroaki;
    • Yamamoto, Nobuyuki;
    • Yoshioka, Hiroshige;
    • Ando, Masahiko;
    • Tamura, Tomohide;
    • Takeda, Koji
    Publication type:
    Article
    28

    Five-year follow-up results from phase II studies of nivolumab in Japanese patients with previously treated advanced non-small cell lung cancer: pooled analysis of the ONO-4538-05 and ONO-4538-06 studies.

    Published in:
    Japanese Journal of Clinical Oncology, 2021, v. 51, n. 1, p. 106, doi. 10.1093/jjco/hyaa157
    By:
    • Saka, Hideo;
    • Nishio, Makoto;
    • Hida, Toyoaki;
    • Nakagawa, Kazuhiko;
    • Sakai, Hiroshi;
    • Nogami, Naoyuki;
    • Atagi, Shinji;
    • Takahashi, Toshiaki;
    • Horinouchi, Hidehito;
    • Takenoyama, Mitsuhiro;
    • Katakami, Nobuyuki;
    • Tanaka, Hiroshi;
    • Takeda, Koji;
    • Satouchi, Miyako;
    • Isobe, Hiroshi;
    • Maemondo, Makoto;
    • Goto, Koichi;
    • Hirashima, Tomonori;
    • Minato, Koichi;
    • Yada, Nobumichi
    Publication type:
    Article
    29

    Phase I/II study of intermitted erlotinib in combination with docetaxel in patients with recurrent non-small cell lung cancer (WJOG4708L).

    Published in:
    Japanese Journal of Clinical Oncology, 2019, v. 49, n. 10, p. 947, doi. 10.1093/jjco/hyz088
    By:
    • Kimura, Tatsuo;
    • Kawaguchi, Tomoya;
    • Chiba, Yasutaka;
    • Yoshioka, Hiroshige;
    • Watanabe, Katsuya;
    • Kijima, Takashi;
    • Kogure, Yoshihito;
    • Oguri, Tetsuya;
    • Yoshimura, Naruo;
    • Niwa, Takashi;
    • Kasai, Takashi;
    • Hayashi, Hidetoshi;
    • Ono, Akira;
    • Asai, Kazuhisa;
    • Tanaka, Hiroshi;
    • Yano, Seiji;
    • Yamamoto, Nobuyuki;
    • Nakanishi, Yoichi;
    • Nakagawa, Kazuhiko
    Publication type:
    Article
    30
    31
    32

    Phase 3 study of ceritinib vs chemotherapy in ALK-rearranged NSCLC patients previously treated with chemotherapy and crizotinib (ASCEND-5): Japanese subset.

    Published in:
    Japanese Journal of Clinical Oncology, 2018, v. 48, n. 4, p. 367, doi. 10.1093/jjco/hyy016
    By:
    • Katsuyuki Kiura;
    • Fumio Imamura;
    • Hiroshi Kagamu;
    • Shingo Matsumoto;
    • Toyoaki Hida;
    • Kazuhiko Nakagawa;
    • Miyako Satouchi;
    • Isamu Okamoto;
    • Mitsuhiro Takenoyama;
    • Yasuhito Fujisaka;
    • Takayasu Kurata;
    • Masayuki Ito;
    • Kota Tokushige;
    • Hatano, Ben;
    • Makoto Nishio
    Publication type:
    Article
    33
    34
    35
    36
    37
    38
    39
    40
    41

    A Phase II Study of Cisplatin and Irinotecan As Induction Chemotherapy Followed by Concomitant Thoracic Radiotherapy with Weekly Low-dose Irinotecan in Unresectable, Stage III, Non-Small Cell Lung Cancer: JCOG 9706.

    Published in:
    Japanese Journal of Clinical Oncology, 2011, v. 41, n. 1, p. 25, doi. 10.1093/jjco/hyq163
    By:
    • Takeda, Koji;
    • Negoro, Shunichi;
    • Tanaka, Masahiro;
    • Fukuda, Haruhiko;
    • Nakagawa, Kazuhiko;
    • Kawahara, Masaaki;
    • Semba, Hiroshi;
    • Kudoh, Shinzoh;
    • Sawa, Toshiyuki;
    • Saijo, Nagahiro;
    • Fukuoka, Masahiro
    Publication type:
    Article
    42
    43
    44
    45
    46
    47
    48
    49
    50